Aquestive Therapeutics, Inc.'s (NASDAQ:AQST) Large Institutional Owners Must Be Happy as Stock Continues to Impress, up 13% Over the Past Week

Simply Wall StNov 29 08:30 ET

US Manufacturing Index Rises To 43, Highest Since 2020

Business TodayNov 16 02:13 ET

Aquestive Therapeutics: Strong Buy Rating Driven by Robust Revenue Performance and Strategic Positioning in Allergy Treatment

TipRanksNov 7 02:06 ET · Ratings

Aquestive Therapeutics Advances Drug Candidates Amid Challenges

TipRanksNov 6 16:40 ET

Lake Street Maintains Aquestive Therapeutics(AQST.US) With Buy Rating, Raises Target Price to $10

Moomoo NewsNov 6 09:33 ET · Ratings

H.C. Wainwright Maintains Aquestive Therapeutics(AQST.US) With Buy Rating, Maintains Target Price $10

Moomoo NewsNov 6 06:31 ET · Ratings